Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-11-04
1998-09-15
Wilson, James O.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514868, 424 117, 424 173, 4241591, 4242111, 4242131, A61K 3170
Patent
active
058078401
ABSTRACT:
The present invention discloses a method for treating patients having the CDV associated symptoms or animals carrying or infected by the canine distemper virus (CDV) or having antibodies against the CDV using Product R, a peptide-nucleic acid preparation.
REFERENCES:
Reynolds, Margaret R., Generalized Vaccinia, Symposium, pp. 5-6, 1960.
Kuckku, Morris E., Herpetic Diseases, Symposium, pp. 7-13, 1960.
Schaeffer, Oden A., Influenza, Symposium, pp. 15-21, 1960.
Seydel, Frank, Epidemic, Asian Influenza, Symposium, pp. 23-24 1960.
Cooke, Stanford B., Upper Respiratory Viral Manifestations, Clinical Symposium on Viral Diseases Demonstrating the Anti-viral Biotic Properties of the Drug Reticulose (Symposium), Sep., 1960, Miami Beach, Fla., pp. 25-32.
Medoff, Lawrence R.r., Infectious Mononucleosis, Symposium, pp. 33-37, 1960.
Anderson, Robert H., Encephalitis, Symposium, pp. 39-52, 1960.
Plucinski, Stanisloff J., Suspected Viral Varieties, Symposium, pp. 53-59, 1960.
Anderson, Robert H. and Thompson, Ralph M., Treatment of Viral Syndrome with a Lipoprotein-Nucleic Acid Compound (Reticulose), A Report of Five Cases, Virginia Medical Monthly, 84:347-353, 1957.
Reynolds, Margaret R., Generalized Vaccinia Successfully Treated With Lipoprotein-Nucleic Acid Complex (Reticulose), Archives of Pediatrics, 77:421-422, 1960.
Wegryn, Stanley P. Marks, Robert A. and Baugh, John R., Herpes Gestationis, A Report of 2 Cases, American Journal of Obstetrics and Gynecology, 79:812-814, 1960.
Catterall, R.A., Lumpur, Kuala, A New Treatment of Herpes Zoster, Vaccinia And Chicken Pox, J. Roy, Coll. Gen. Practit., 1970, 19, 182.
Chinnici, Angelo A., Reticulose in Treatment Aids patients, Personal Communication to William Bregman, Jul. 6, 1992.
Cott, Rafael A., Summary of 11 Cases of Viral Infections Treated with Reticulose, Private Communication with Advance Viral Research Corp., 1989.
Cohen, Matthew, The Efficacy of a Peptide-Nucleic Acid Solution (Reticulose) for the Treatment of Hepatitis A and Hepatitis B -a Preliminary Controlled Human Clinical Trial, J. Roy. Soc. Health, Dec., 1992, 266-270.
Mundschenk, David D., In Vitro Antiviral Activity of Reticulose vs Influenaz A, Personal Communication with William Bregman, May 1, 1990.
Resnick, Lionel, Anti-HIV in Vitro Activity of Two Samples of Peptide-nucleic Acid Solution, Personal Communication with Dr. Bernard Friedland, Dec. 22, 1989.
Friedland, Bernard, In Vitro Antiviral Activity of a Peptide-Nucleic Acid Solution Against the Human Immunodeficiency Virus and Influenza A Virus, J. Roy. Soc. Health, Oct. 1991, 170-171.
Brazier, Anne D., Method for in Vitro Antiviral Evaluation Human Immunodeficiency Virus (HIV), Personal Communication with Dr. Bernard Friedland, Oct. 4, 1989.
Behbehani, Abbas M., Haberman Sol and Race, George J, The Effect of Reticulose on Viral Infections of Experimental Animals, Southern Medical Journal, Feb., 1962, 185-188.
Treatment of Viral Diseases with A Lipo-protein Nucleic Acid Complex (Reticulose) -A Clinical Study, Scientific Exhibit: Virginia State Medical Society Meeting, Washington D.C., Nov., 1957.
Kempe, Henry C., Fulginiti, Vincent A., and Vincent, Leone St., Failure to Demonstrate Antiviral Activity of Reticulose, Diseases of Children, vol. 103, No. 5, 655-657, 1962.
Sanders, Murray, Controlled Animal Studies with Reticulose Illustrating the Interference of Lipoprotein-Nucleic Acid Complex in the Experimental Animal Infected with Human Pathogenic Viral Entities, Southern Medical Association Scientific Exhibit, Dallas, Texas, Nov., 1961.
Advanced Viral Research Corp.
Wilson James O.
LandOfFree
Method for treating canine distemper does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating canine distemper, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating canine distemper will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-87298